These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5036805)

  • 1. [Clinical and morphological study of the skin in patients with vitiligo during treatment with psoralen].
    Arutiunov VIa; Arkhangel'skaia NV; Uzhvieva NV
    Vestn Dermatol Venerol; 1972 Feb; 46(2):8-12. PubMed ID: 5036805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histochemical changes in the skin of patients with vitiligo during treatment with Psoralen].
    Abdullakhodzhaeva MS; Abidov MM
    Vestn Dermatol Venerol; 1968 Jan; 42(1):24-6. PubMed ID: 5741206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prospects of the use of preparations of the psoralen group in the treatment of vitiligo patients].
    Zheltakov MM; Vinokurov IN
    Sov Med; 1966 Aug; 29(8):110-5. PubMed ID: 5991379
    [No Abstract]   [Full Text] [Related]  

  • 4. [Copper metabolism disorders in vitiligo].
    Huriez C; Bizerte ; Dequidt ; Bialais
    Ann Dermatol Syphiligr (Paris); 1972; 99(1):29-40. PubMed ID: 4626473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current points of view on the therapy of vitiligo].
    Ormea F
    Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the effectiveness of vitiligo treatment with psoralens; studies of the action mechanism].
    Rudowska I
    Asthet Med (Berl); 1968 May; 17(5):117-24. PubMed ID: 4180779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia].
    Braĭtsev AV
    Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of psoberan in vitiligo].
    Mirakhmedov UM; Abidov MM
    Vestn Dermatol Venerol; 1976 Feb; (2):77-9. PubMed ID: 936777
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
    Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of psoralene on pigmentation in the hypophysectomized toad (Bufo melanostictus).
    Biswas NM; Deb C; Haque M; Chakraborty DP
    Endokrinologie; 1967; 52(3):271-5. PubMed ID: 5589138
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitiligo--treatment with trimethylpsoralen.
    Bleehen SS
    Br J Dermatol; 1971 Feb; 84(2):186-8. PubMed ID: 5548475
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
    De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
    Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [4-5-8 trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children].
    Ruíz Maldonado R; Tamayo Sánchez L
    Actas Dermosifiliogr; 1975; 66(9-10):513-26. PubMed ID: 1199825
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complex treatment of patients with vitiligo].
    Borisenko KK
    Sov Med; 1973 Feb; 36(2):123-7. PubMed ID: 4764967
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo.
    Mayoral FA; Vega JM; Stavisky H; McCormick CL; Parneix-Spake A
    J Drugs Dermatol; 2007 May; 6(5):517-21. PubMed ID: 17679186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
    Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of vitiligo using oral Trisoralen].
    Karadaglić D; Stefanović Z; Mijailović B
    Zb Vojnomed Akad; 1976; (18):74-6. PubMed ID: 1074341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.